Zoe Yandle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zoe Yandle has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
S. Coughlan
UCD National Virus Reference Laboratory, University College Dublin, Dublin 4, Ireland
4 shared publicationsC. De Gascun
UCD National Virus Reference Laboratory, University College Dublin, Dublin 4, Ireland
3 shared publicationsJelle Matthijnssens
University of Leuven (KU Leuven), Department of Microbiology, Immunology and Transplantation, Rega Institute, Division of Clinical and Epidemiological Virology, Laboratory of Viral Metagenomics, Leuven, Belgium
2 shared publicationsAllen Doyle
Emergency Department, St. Vincent's University Hospital, Dublin 4, Ireland
1 shared publication- Anne Conroy
UCD National Virus Reference Laboratory, University College Dublin, Dublin 4, Ireland
1 shared publication Aoife Colgan
HSE-Health Protection Surveillance Centre (HPSC), 25-27 Middle Gardiner Street, Dublin D01 A4A3, Ireland
1 shared publication
Latest Publications
- Open Access
- 29 October 2025
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 135, 105848
Complex evolutionary dynamics including reassortment drive genome diversity in human rotavirus species A circulating in Ireland
- 29 October 2025
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 135, 105848
Open AccessComplex evolutionary dynamics including reassortment drive genome diversity in human rotavirus species A circulating in Ireland
- 6 December 2022
- Published by Elsevier in Journal of Virological Methods
- Vol. 312, 114664
A viral metagenomic protocol for nanopore sequencing of group A rotavirus
- 6 December 2022
- Published by Elsevier in Journal of Virological Methods
- Vol. 312, 114664
A viral metagenomic protocol for nanopore sequencing of group A rotavirus
- 1 April 2021
- Published by Elsevier in Journal of Clinical Virology
- Vol. 137, 104780
Indirect impact of rotavirus vaccination on viral causes of acute gastroenteritis in the elderly
- 1 April 2021
- Published by Elsevier in Journal of Clinical Virology
- Vol. 137, 104780
Indirect impact of rotavirus vaccination on viral causes of acute gastroenteritis in the elderly
- Open Access
Group A Rotavirus Detection and Genotype Distribution before and after Introduction of a National Immunisation Programme in Ireland: 2015–2019
Immunisation against rotavirus infection was introduced into Ireland in December 2016. We report on the viruses causing gastroenteritis before (2015–2016) and after (2017–2019) implementation of the Rotarix vaccine, as well as changes in the diversity of circulating rotavirus genotypes. Samples from patients aged ≤ 5 years (n = 11,800) were received at the National Virus Reference Laboratory, Dublin, and tested by real-time RT-PCR for rotavirus, Rotarix, norovirus, sapovirus, astrovirus, and enteric adenovirus. Rotavirus genotyping was performed either by multiplex or hemi-nested RT-PCR, and a subset was characterised by sequence analysis. Rotavirus detection decreased by 91% in children aged 0–12 months between 2015/16 and 2018/19. Rotarix was detected in 10% of those eligible for the vaccine and was not found in those aged >7 months. Rotavirus typically peaks in March–May, but following vaccination, the seasonality became less defined. In 2015–16, G1P[8] was the most common genotype circulating; however, in 2019 G2P[4] was detected more often. Following the introduction of Rotarix, a reduction in numbers of rotavirus infections occurred, coinciding with an increase in genotype diversity, along with the first recorded detection of an equine-like G3 strain in Ireland.
Open AccessGroup A Rotavirus Detection and Genotype Distribution before and after Introduction of a National Immunisation Programme in Ireland: 2015–2019
Immunisation against rotavirus infection was introduced into Ireland in December 2016. We report on the viruses causing gastroenteritis before (2015–2016) and after (2017–2019) implementation of the Rotarix vaccine, as well as changes in the diversity of circulating rotavirus genotypes. Samples from patients aged ≤ 5 years (n = 11,800) were received at the National Virus Reference Laboratory, Dublin, and tested by real-time RT-PCR for rotavirus, Rotarix, norovirus, sapovirus, astrovirus, and enteric adenovirus. Rotavirus genotyping was performed either by multiplex or hemi-nested RT-PCR, and a subset was characterised by sequence analysis. Rotavirus detection decreased by 91% in children aged 0–12 months between 2015/16 and 2018/19. Rotarix was detected in 10% of those eligible for the vaccine and was not found in those aged >7 months. Rotavirus typically peaks in March–May, but following vaccination, the seasonality became less defined. In 2015–16, G1P[8] was the most common genotype circulating; however, in 2019 G2P[4] was detected more often. Following the introduction of Rotarix, a reduction in numbers of rotavirus infections occurred, coinciding with an increase in genotype diversity, along with the first recorded detection of an equine-like G3 strain in Ireland.
- 5 May 2017
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 186 (4) , 1003-1007
Circulating rotavirus genotypes in the Irish paediatric population prior to the introduction of the vaccination programme
Rotavirus is the leading cause of viral gastroenteritis in children, and it is anticipated that the introduction of the Rotarix™ vaccine (GlaxoSmithKline Biologicals S.A., Rixensart, Belgium) into the Irish immunisation schedule will result in a significant reduction of rotavirus-associated disease. In the pre- and post-vaccination eras, it is important to determine circulating strains of rotavirus to assess vaccine effectiveness, to monitor vaccine failures, and to detect potential emerging strains.
- 5 May 2017
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 186 (4) , 1003-1007
Circulating rotavirus genotypes in the Irish paediatric population prior to the introduction of the vaccination programme
Rotavirus is the leading cause of viral gastroenteritis in children, and it is anticipated that the introduction of the Rotarix™ vaccine (GlaxoSmithKline Biologicals S.A., Rixensart, Belgium) into the Irish immunisation schedule will result in a significant reduction of rotavirus-associated disease. In the pre- and post-vaccination eras, it is important to determine circulating strains of rotavirus to assess vaccine effectiveness, to monitor vaccine failures, and to detect potential emerging strains.
- 10 February 2017
- Published by Frontiers Media SA in British Journal of Biomedical Science
- Vol. 74 (3) , 144-147
Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting
(2017). Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting. British Journal of Biomedical Science: Vol. 74, No. 3, pp. 144-147.
- 10 February 2017
- Published by Frontiers Media SA in British Journal of Biomedical Science
- Vol. 74 (3) , 144-147
Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting
(2017). Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting. British Journal of Biomedical Science: Vol. 74, No. 3, pp. 144-147.
- 1 September 2016
- Published by Elsevier in Journal of Clinical Virology
- Vol. 82, S60-S61
Detection and characterisation of viral pathogens causing gastroenteritis in Ireland, 2014–2016
- 1 September 2016
- Published by Elsevier in Journal of Clinical Virology
- Vol. 82, S60-S61
Detection and characterisation of viral pathogens causing gastroenteritis in Ireland, 2014–2016
- 1 January 2010
- Published by Elsevier in Journal of Virological Methods
- Vol. 163 (1) , 17-24
A low density oligonucleotide microarray for the detection of viral and atypical bacterial respiratory pathogens
- 1 January 2010
- Published by Elsevier in Journal of Virological Methods
- Vol. 163 (1) , 17-24
A low density oligonucleotide microarray for the detection of viral and atypical bacterial respiratory pathogens